FDA Clearance Tracker · P040023-S021
DURALOC OPTION CERAMIC HIP SYSTEM
Last checked: Nov 20, 2026Latest source record: Jun 15, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Jun 15, 2012
Approved
Time to decision
58 days
Received Apr 18, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040023-S021
- Device name
- DURALOC OPTION CERAMIC HIP SYSTEM
- Applicant
- DePuy Orthopaedics, Inc.
- Applicant location
- Warsaw, IN
- Received
- Apr 18, 2012
- Decided
- Jun 15, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P040023
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for DePuy Orthopaedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262130 · Decided Sep 4, 2026 · 72 days after receipt
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.